Muscular Dystrophy Canada (MDC) and the Neuromuscular Disease Network for Canada (NMD4C) are pleased to invite you to a webinar on interdisciplinary guidelines for Myotonic Dystrophy Type 1.
This webinar is primarily targeted at Canadian clinicians, academics and trainees with an interest in neuromuscular disease.
NMD4C and MDC are providing organisational and technical support, and this is an independent clinical/academic webinar with no industry sponsorship.
The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
International clinical guidelines for adult Myotonic Dystrophy Type 1 (DM1): an allied health perspective - Cynthia Gagnon, PhD
Exercise prescription for adult DM1: what do we know - Élise Duchesne, PhD
International clinical guidelines for congenital DM1 - Craig Campbell, MD, Cam-Tu Nguyen
Webinar Learning Objectives:
At the end of the presentation, the attendees will be able to identify:
1) Key management areas among the most frequent phenotypes of DM1
2) Key treatment perspectives in DM1
3) Life threatening complications related to DM1 management
If you have any questions, please email email@example.com
If you would like to learn more about NMD4C and to become a member: https://neuromuscularnetwork.ca/become-a-member/